Commercial-stage biotech TG Therapeutics (NASDAQ: TGTX) was having a fine week on the stock exchange, thanks in no small part to an investor-pleasing earnings report. It unveiled its first-quarter fundamentals on Wednesday, and was quite the hot item in subsequent days. According
(RTTNews) - French banking company Credit Agricole Group (CRARF.PK, CDA.L, ACA.PA) reported Friday that its first-quarter net income Group share climbed 42.8 percent to 2.384 billion euros from last year's 1.669 billion euros.
(RTTNews) - French financial services provider Societe Generale S.A. (SCGLF.PK, SCGLY.PK) reported Friday that its first-quarter Group net income fell 21.7 percent to 680 million euros from last year's 868 million euros.
(RTTNews) - Indian shares opened higher on Friday amid a global rally as traders pulled forward expectations for the Federal Reserve's first interest-rate cut by a month to November.
In this podcast, Motley Fool host Dylan Lewis and analyst Mason Moser talk about Tesla's down results and up market reaction, how Boeing's backlog insulates it from short-term delivery hiccups, and why Visa's results are boring...and that's A-OK.
(RTTNews) - Soleno Therapeutics Inc. (SLNO) said that it has priced underwritten public offering of 3 million shares of its common stock at $46.00 per share.